SCHEMBL20206906

SCHEMBL20206906

COC1CN(c2cc(C(N)=O)cc(-c3cnn4ccc(-c5ccccc5)nc34)n2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 6/20 0.54
KCNH2 Q12809 2/20 0.54
CAMKK1 Q8N5S9 1/20 0.45
CAMKK2 Q96RR4 1/20 0.45
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
PIK3CG P48736 1/20 0.40
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
PIK3CD O00329 2/20 0.38
PIM1 P11309 3/20 0.37
PIM2 Q9P1W9 2/20 0.37
RET P07949 3/20 0.36
PRKD1 Q15139 1/20 0.35
PRKD2 Q9BZL6 1/20 0.35
NTRK1 P04629 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20207097 0.86 CAMK2D (0.71) CAMK2DKCNH2
SCHEMBL20186381 0.86 CAMK2D (0.65) CAMK2DKCNH2CAMKK1CAMKK2
SCHEMBL20186664 0.86 CAMK2D (0.49) CAMK2DKCNH2CAMKK1CAMKK2PIK3CD
SCHEMBL20186380 0.86 CAMK2D (0.65) CAMK2DKCNH2CAMKK1CAMKK2
SCHEMBL20186661 0.86 CAMK2D (0.49) CAMK2DKCNH2CAMKK1CAMKK2PIK3CD
SCHEMBL20186165 0.86 CAMK2D (0.55) CAMK2DKCNH2CAMKK1CAMKK2
SCHEMBL20225439 0.84 CAMK2D (0.47) CAMK2DKCNH2CAMKK1CAMKK2MAPT
SCHEMBL22923501 0.84 CAMK2D (0.47) CAMK2DKCNH2CAMKK1CAMKK2MAPT
SCHEMBL20186179 0.84 CAMK2D (0.55) CAMK2DKCNH2CAMKK1CAMKK2MEN1
SCHEMBL20186411 0.83 CAMK2D (0.64) CAMK2DKCNH2CAMKK1CAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148457-A1 FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS GILEAD SCIENCES, INC. 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148457-A1 FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS CAMK1, CAMKK1, CAMK1D CAMK2D 6/4885KCNH2 388/4885CAMKK1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.